Navigation Links
America's Pharmaceutical Research Companies Respond to Hurricane Ike's Imminent Landfall
Date:9/12/2008

WASHINGTON, Sept. 12 /PRNewswire-USNewswire/ -- Responding to conditions created by Hurricane Ike in Texas and other Gulf Coast states, the Pharmaceutical Research and Manufacturers of America (PhRMA) has moved from "alert" to "engaged" status - the highest level of activation - as part of its effort to ensure needed medicines are available in areas affected by the storm. PhRMA is working closely with other members of the RxResponse network, http://www.rxresponse.org, to provide assistance to state, local and federal emergency managers to keep the pharmaceutical supply chain open throughout areas hit by Ike.

PhRMA, along with other RxResponse Coordinating Body members, are now convening regular conference calls to manage RxResponse's efforts to coordinate requests for needed medicines and supplies, as well as other critical information about the state of the pharmaceutical supply system throughout the affected region. PhRMA is specifically coordinating with its member companies and asking them to advise the RxResponse team of Ike-related impacts on company operations, as well as to monitor and report all requests for assistance.

"We will do all we can to assist emergency managers in Texas and everyone affected by Hurricane Ike," said PhRMA President & CEO Billy Tauzin. "We are working together with key players in the pharmaceutical supply system and with emergency managers on the ground to help ensure that medicines get to the patients, hospitals and emergency evacuation centers where they are needed most."

Created following Hurricane Katrina, RxResponse is a unique business-sector effort creating a single point of contact for emergency managers and public health leaders seeking help obtaining needed medicines after a natural or man-made disaster. The RxResponse is comprised of: the American Hospital Association, the American Red Cross, the Biotechnology Industry Organization, the Generic Pharmaceutical Association, the Healthcare Distribution Management Association, the National Community Pharmacists' Association and PhRMA.

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $44.5 billion in 2007 in discovering and developing new medicines. Industry-wide research and investment reached a record $58.8 billion in 2007.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For information on the danger of imported drugs, visit: http://www.buysafedrugs.info


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ExamForce Hires Former (ISC)2 Americas Leader to Head Corporate and Government Sales Efforts
2. Mentice, Inc. Expands Its North American Sales and Clinical Presence With the Hiring of Jeff Sirek as Director of Educational Sales-East and Sue Landsman as Clinical Applications Manager for the Americas.
3. DNA Find in Oregon Is Oldest Yet Discovered in Americas
4. Olympus Corporation of the Americas Names Mark Gumz President & CEO
5. Mentice, Inc. Announces Appointment of Vice-President, Sales and Marketing, Americas
6. Cochlear Americas Announces 2008 Graeme Clark Scholarship Winners
7. Genesis Pharmaceuticals Received New Purchase Orders Worth $12 Million
8. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Laonian Kechuan Tablets
9. DSM Pharmaceutical Products Announces the Appointment of Thats Nice LLC as Agency of Record for Marketing
10. Mylan to Retain Dey, L.P., Its Specialty Pharmaceutical Subsidiary
11. WellSpring Pharmaceutical Corp. Acquires Consumer Product Brands from McNeil Consumer Healthcare -- Deal Enhances US and Canadian Pharmaceutical Business
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... DC (PRWEB) , ... April 24, 2017 , ... The ... recognized during ATA 2017: Telehealth 2.0 — the American Telemedicine Association’s annual conference, on ... Santana Telehealth Project for using telemedicine to improve the lives of the poor and ...
(Date:4/24/2017)... IL (PRWEB) , ... April 24, 2017 , ... Today, Bright Pink , a ... in young women, names a new CEO. , Bright Pink is proud to announce ... she would be moving to a new role as Chairman of the Board and ...
(Date:4/24/2017)... Raton, Florida (PRWEB) , ... April 24, 2017 ... ... develops a variety of unique liquid food supplements, announced its popular products are ... nutritional products. , ALP Nutrition® prioritizes the use of premium natural ingredients ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... (CDC), rising prescription opioid overdose deaths now claim the lives of 62 Americans ... civil case filings against drug manufacturers, distributors, pharmacies and prescribers by more than ...
(Date:4/24/2017)... ... 24, 2017 , ... As a former supermodel known for her timeless beauty, ... for single women is that she put all the words in her new book, ... insight, personal experiences and sparkling sense of humor have inspired her to write a ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, ... their offering. ... pharmacogenomics market was valued at US$ 7,167.6 Mn in 2015, ... expanding at a CAGR of 5.6% from 2016 to 2024. ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
(Date:4/19/2017)... , April 19, 2017 The Mobile X-Ray product ... a healthy CAGR during the forecast period Mobile ... the global digital mobile X-Ray devices market, which is estimated ... 2017, expanding at a CAGR of 7% over the forecast ... opportunity of more than US$ 100 Mn in 2017 over ...
Breaking Medicine Technology: